Ratings Summary for FOSAMAX

Overall Patient opinion of FOSAMAX: 1.4 (extremely dissatisfied)

(based on 1232 reviews ) (updated May 6, 2025)

Ratings by Age Group for FOSAMAX
Rating Scale from 1 (poor) to 5 (excellent)

Patient Age Group	Number of Reviews	Average Rating
Pediatric (Under 18)	1	2
Age 18 to 24	5	2.4
Age 25 to 34	15	2.4
Age 35 to 44	35	1.6
Age 45 to 54	277	1.4
Age 55 to 64	533	1.4
Age 65 to 74	289	1.4
Age 75 and up	53	1.2

Ratings by Sex for FOSAMAX
Rating Scale from 1 (poor) to 5 (excellent)

Patient Sex	Number of Reviews	Average Rating
Male	84	1.67857142857143
Female	1127	1.44454303460515
Not Specified	19	1.26315789473684

Would you like to find reviews for FOSAMAX taken for a specific reason or resulting in a specific side effect?

Filter Results for FOSAMAX

Patient Type:	Any Male Female
Reason(s):
Side Effect(s):
Satisfaction:	1 2 3 4 5

FDA Drug Safety Information for FOSAMAX

Check here for Ask a Patient's Adverse Event Summary for FOSAMAX based on cases submitted to the FDA. Includes top reasons for taking, adverse events, and major outcomes reported.

FOSAMAX (ALENDRONATE SODIUM): Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age, after menopause, or if you are taking corticosteroid medications (such as prednisone) for a long time. This medication works by slowing bone loss. This effect helps maintain strong bones and reduce the risk of broken bones (fractures). Alendronate belongs to a class of drugs called bisphosphonates. FDA Approval Date: 2000-10-20 (Sources: U.S. Centers for Medicare Services, FDA)

Patient Counseling Information from Official Drug Label

The above Patient Counseling and/or Medication Guide for FOSAMAX is from the official drug label (including Section 17) obtained from the National Library of Medicine's DailyMed database.
Please refer to the complete label here Official Drug Label for FOSAMAX.